Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in the ...
ReMarkable's Paper Pro Move tablet has the same satisfying writing experience, but in a pocket-sized form factor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback